Coagulation Factor IX anticorps (AA 217-423)
Aperçu rapide pour Coagulation Factor IX anticorps (AA 217-423) (ABIN1886209)
Antigène
Voir toutes Coagulation Factor IX (F9) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 217-423
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 217 and 423 of Human F9
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- Coagulation Factor IX (F9)
-
Autre désignation
- Factor IX
-
Sujet
-
This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen.This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds.The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII.Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease.[provided by RefSeq]
-
Poids moléculaire
- 52 kDa
-
ID gène
- 2158
Antigène
-